HCP5 has already been related to TNBC progression by regulating miR-219a-5p/BIRC3 [89]; also, its high expression was related to cisplatin resistance in the TNBC cell line [90] and associated with BC poor prognosis [91]. This evidence concerns the gene HCP5 and breast cancer.